Skip to content

Insider · CIK 0001548072

Franz B Humer

director

Files at ALLO (Allogene Therapeutics, Inc.). First filing Dec 9, 2024, latest Dec 9, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $20k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ALLO: Allogene Therapeutics, Inc.

ALLOOct 9, 2026 · close 1.46

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
23Weak
ALLOsell 2
Allogene Therapeutics, Inc.
$20k
9,221 shares
-3%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 18, 2025ALLO
Allogene Therapeutics, Inc.
AGrant or award
Restricted Stock Unitderivative
+95,400$0.00$095,400Jun 23, 2025
Dec 5, 2024ALLO
Allogene Therapeutics, Inc.
SOpen-market sale
Common Stock
-9,221$2.16$20k307,507Dec 9, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Franz B Humer: insider trades and track record | InsiderTell